Cardiovascular benefits of omega-3 polyunsaturated fatty acids / edited by B. Maisch and R. Oelze.

Format:

Book

Contributor:

Maisch, Bernhard.

Oelze, R.

Series:

Solvay Pharmaceuticals Conferences ; v. 7.

Solvay Pharmaceuticals Conferences, 1566-7685 ; v. 7

Language:

English

Subjects (All):

Heart--Diseases--Congresses.

Heart.

Omega-3 fatty acids--Therapeutic use--Congresses.

Omega-3 fatty acids.

Physical Description:

1 online resource (196 p.)

Edition:

1st ed.

Place of Publication:

Amsterdam ; Washington, DC : IOS Press, c2006.

Language Note:

English

Summary:

Solvay Pharmaceuticals Conferences

Contents:

Title page; Preface; List of Contributors; Contents; Conference Preface; Keynote Lecture - Risk Factors for Atherosclerotic Disease: Present and Future; Microdetermination of Fatty Acids by Gas Chromatography and Cardiovascular Risk Stratification by the ""EPA+DHA Level""; Highly Purified Omega-3 Polyunsaturated Fatty Acids Are Effective as Adjunct Therapy for Secondary Prevention of Myocardial Infarction: Critical Analysis of GISSI-Prevenzione Trial; Prevention of Cardiovascular Diseases and Highly Concentrated n-3 Polyunsaturated Fatty Acids (PUFAs)

Omega-3 Fatty Acids and Sudden Arrhythmic DeathDepression and Coronary Artery Disease: Epidemiology and Potential Mechanisms; Effects of Omega-3 Polyunsaturated Fatty Acids on Depression; A Multi-Country Health-Economic Evaluation of Highly Concentrated n-3 Polyunsaturated Fatty Acids (PUFAs) in the Secondary Prevention After Myocardial Infarction (MI); OMACOR® in Clinical Development: A Survey of Current Trials; Author Index

Notes:

Held during the European Cardiology Society Congress in Stockholm in 2005.

Includes bibliographical references and index.

ISBN:

6610810575

1-280-81057-2

9786610810574

1-4294-6773-8

1-60750-222-4

600-00-0360-9

1-4337-0156-1

OCLC:

347009849